Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
348 studies found for:    04-21
Show Display Options
Rank Status Study
1 Active, not recruiting Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Conditions: Myelodysplastic Syndromes;   MDS;   RAEB;   Chronic Myelomonocytic Leukemia
Intervention: Drug: ON 01910.Na
2 Unknown  Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage
Condition: Subarachnoid Hemorrhage
Intervention:
3 Completed Topical Therapy for Prevention of Infections in Preterm Infants
Condition: Skin Diseases
Interventions: Drug: Aquaphor;   Drug: Sunflower Seed Oil
4 Completed Taxoprexin Treatment for Advanced Skin Melanoma
Condition: Metastatic Melanoma
Intervention: Drug: Taxoprexin
5 Recruiting Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
Condition: Depression
Interventions: Device: C-ECT;   Drug: PHARMACOTHERAPY
6 Active, not recruiting ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial
Conditions: Oral Mucositis;   Nausea;   Vomiting;   Diarrhea
Intervention: Device: ProThelial
7 Not yet recruiting Efficacy Study Comparing VELCADE DEXAMETHASONE THALIDOMIDE Versus VELCADE CYCLOPHOSPHAMIDE DEXAMETHASONE as Induction Treatment in the Initial Management of Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: Thalidomide®;   Drug: Cyclophosphamide;   Drug: Velcade®;   Drug: Dexaméthasone
8 Completed Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy
Condition: Diffuse Large B-Cell Lymphoma
Interventions: Drug: CHOP21-R;   Drug: Zevalin
9 Recruiting BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Conditions: Solid Tumor;   Hematologic Malignancies
Intervention: Drug: BGJ398
10 Unknown  Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer Screening
Condition: Prostate Cancer
Intervention: Behavioral: Computer-based prostate cancer screening decision aid
11 Completed Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening
Condition: Prostate Cancer
Intervention: Behavioral: Educational Intervention to Increase Informed Decision Making for Prostate Cancer Screening
12 Completed Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide
Conditions: Anaplastic Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma
Interventions: Drug: Temozolomide;   Radiation: Focal radiotherapy
13 Active, not recruiting ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer
Conditions: Biliary Tract Neoplasms;   Cholangiocarcinoma;   Gallbladder Neoplasms
Interventions: Drug: selumetinib;   Drug: gemcitabine;   Drug: cisplatin
14 Completed Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers
Conditions: Melanoma;   Breast Cancer;   Prostate Cancer
Intervention: Drug: CVA21
15 Active, not recruiting Dose-escalation Study of Combination BMS-936558 (MDX-1106) and Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
Condition: Malignant Melanoma
Interventions: Drug: BMS-936558 (MDX1106-04);   Drug: Ipilimumab
16 Recruiting A Clinical Evaluation Of The Safety Of Baclofen Er Capsules (Grs) When Administered Once Daily To Subjects With Spasticity Due To Multiple Sclerosis (Ms): An Open Label, Long Term, Safety Trial
Condition: Spasticity
Intervention: Drug: Baclofen
17 Completed
Has Results
Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement
Condition: Prostatic Hyperplasia
Interventions: Drug: Dutasteride plus tamsulosin;   Drug: tamsulosin
18 Recruiting A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)
Condition: Early Breast Cancer
Interventions: Biological: PF-05280014;   Drug: Taxotere®;   Drug: Paraplatin®;   Biological: Trastuzumab-EU
19 Completed Safety Study of F2695 SR in Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: F2695 SR
20 Completed
Has Results
Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney Disease
Conditions: Anemia;   Chronic Kidney Disease
Intervention: Drug: darbepoetin alfa

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years